Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Breast 1

Conditions

Prostatic Neoplasms 2Inflammation 2Stomach Neoplasms 1Pancreatic Neoplasms 1Pain, Postoperative 1Pain 1Gynecological Laparoscopic Surgery 1Esophageal Neoplasms 1Emergence Delirium 1Carcinoma, Intraductal, Noninfiltrating 1Carcinoma, Hepatocellular 1Breast Neoplasms 1

Interventions

Tamoxifen 12Chemotherapy, Adjuvant 9Radiotherapy 7Anastrozole 6Neoadjuvant Therapy 5Magnetic Resonance Spectroscopy 5Letrozole 5Gene Expression Profiling 5Psychiatric Rehabilitation 4Mass Spectrometry 4Immunohistochemistry 4Early Intervention, Educational 4Counseling 4Sentinel Lymph Node Biopsy 3Reverse Transcriptase Polymerase Chain Reaction 3High-Energy Shock Waves 3Fatty Acids, Omega-3 3Chromatography, High Pressure Liquid 3Biopsy 3afimoxifene 2Trastuzumab 2Surgical Procedures, Operative 2Soybean Proteins 2Simvastatin 2Radiotherapy, Conformal 2Radiation 2Methods 2Mastectomy 2Fish Oils 2Caregivers 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Carcinoma, Intraductal, Noninfiltrating × Sufentanil × Clear all
NCT04248179 2023-02-09

The Ultrasound-guided Multiple-injection Costotransverse Block for Mastectomy and Primary Reconstructive Surgery.

Zealand University Hospital

Phase 4 Completed
36 enrolled
Breast

Breast Neoplasms, Carcinoma, Intraductal, Noninfiltrating, Pain, Postoperative

Data powered by HemOnc (CC BY 4.0) Colophon âš¡